Molecular MRI of hematopoietic stem-progenitor cells:: in vivo monitoring of gene therapy and atherosclerosis

被引:18
作者
Qiu, Bensheng [1 ]
Yang, Xiaoming [1 ]
机构
[1] Univ Washington, Sch Med, Dept Radiol, Image Guided Biomol Intervent Sect, Seattle, WA 98195 USA
来源
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE | 2008年 / 5卷 / 07期
关键词
atherosclerosis; gene therapy; magnetic labeling; molecular MRI; stem-progenitor cells;
D O I
10.1038/ncpcardio1217
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A characteristic feature of atherosclerotic cardiovascular disease is the diffuse involvement of arteries across the entire human body and the presence of multiple, simultaneous lesions. The diffuse nature of this disease creates a unique challenge for early diagnosis and effective treatment. We believe that recent progress in the field of molecular MRI has opened new avenues towards solving the problem. A new technology has been developed that uses molecular MRI to monitor the migration and homing of hematopoietic stem-progenitor cells to injured arteries and atherosclerosis. In this Review, we introduce several novel technical developments in the field of molecular MRI of atherosclerosis, including advanced techniques for magnetic labeling of stem-progenitor cells and molecular MRI of hematopoietic bone marrow cells migrating to injured arteries and homing to atherosclerotic plaques. In addition, we examine molecular MRI of vascular gene therapy mediated by stem-progenitor cells. These new techniques provide the basis for the further development of in vivo MRI techniques to monitor stem-cell-mediated vascular gene therapy for multiple and diffuse atherosclerotic cardiovascular lesions.
引用
收藏
页码:396 / 404
页数:9
相关论文
共 50 条
  • [1] [Anonymous], HEART DIS STROKE STA
  • [2] Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI
    Arbab, AS
    Yocum, GT
    Kalish, H
    Jordan, EK
    Anderson, SA
    Khakoo, AY
    Read, EJ
    Frank, JA
    [J]. BLOOD, 2004, 104 (04) : 1217 - 1223
  • [3] BILLINGHAM ME, 1987, TRANSPLANT P, V19, P19
  • [4] Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells
    Bulte, JWM
    Douglas, T
    Witwer, B
    Zhang, SC
    Strable, E
    Lewis, BK
    Zywicke, H
    Miller, B
    van Gelderen, P
    Moskowitz, BM
    Duncan, ID
    Frank, JA
    [J]. NATURE BIOTECHNOLOGY, 2001, 19 (12) : 1141 - 1147
  • [5] Bulte JWM, 2004, METHOD ENZYMOL, V386, P275
  • [6] MAGNETOFERRITIN - CHARACTERIZATION OF A NOVEL SUPERPARAMAGNETIC MR CONTRAST AGENT
    BULTE, JWM
    DOUGLAS, T
    MANN, S
    FRANKEL, RB
    MOSKOWITZ, BM
    BROOKS, RA
    BAUMGARNER, CD
    VYMAZAL, J
    STRUB, MP
    FRANK, JA
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 1994, 4 (03) : 497 - 505
  • [7] Iron oxide MR contrast agents for molecular and cellular imaging
    Bulte, JWM
    Kraitchman, DL
    [J]. NMR IN BIOMEDICINE, 2004, 17 (07) : 484 - 499
  • [8] Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy
    Daldrup-Link, HE
    Rudelius, M
    Metz, S
    Piontek, G
    Pichler, B
    Settles, M
    Heinzmann, U
    Schlegel, J
    Oostendorp, RAJ
    Rummeny, EJ
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (09) : 1312 - 1321
  • [9] Targeting of hematopoietic progenitor cells with MR contrast agents
    Daldrup-Link, HE
    Rudelius, M
    Oostendorp, RAJ
    Settles, M
    Piontek, G
    Metz, S
    Rosenbrock, H
    Keller, U
    Heinzmann, U
    Rummeny, EJ
    Schlegel, J
    Link, TM
    [J]. RADIOLOGY, 2003, 228 (03) : 760 - 767
  • [10] Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
    de Vries, IJM
    Lesterhuis, WJ
    Barentsz, JO
    Verdijk, P
    van Krieken, JH
    Boerman, OC
    Oyen, WJG
    Bonenkamp, JJ
    Boezeman, JB
    Adema, GJ
    Bulte, JWM
    Scheenen, TWJ
    Punt, CJA
    Heerschap, A
    Figdor, CG
    [J]. NATURE BIOTECHNOLOGY, 2005, 23 (11) : 1407 - 1413